Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Grape King Enterprise is a leading health food and supplement manufacturer and CDMO based in Shanghai, China. As a key subsidiary of the Taiwan-listed Grape King Bio, the company leverages over five decades of expertise in biotechnology and fungal fermentation. They specialize in the research, development, and large-scale production of functional ingredients such as probiotics and medicinal mushrooms, including Ganoderma lucidum and Cordyceps. Shanghai Grape King provides comprehensive ODM and OEM services, offering end-to-end solutions from formulation design to final product manufacturing in various formats like capsules, powders, and functional beverages. Their state-of-the-art facilities are certified under international standards including GMP, ISO 22000, and HACCP, serving a diverse portfolio of global and domestic health brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Grape King Enterprise.